BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wu L, Yu K, Chen K, Zhu X, Yang Z, Wang Q, Gao J, Wang Y, Cao T, Xu H, Pan X, Wang L, Xia J, Li Y, Wang ZP, Ma J. Fbxo45 facilitates pancreatic carcinoma progression by targeting USP49 for ubiquitination and degradation. Cell Death Dis 2022;13:231. [PMID: 35279684 DOI: 10.1038/s41419-022-04675-2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
Number Citing Articles
1 Liu Y, Liu J, Zhang X, Guo C, Xing X, Zhang ZM, Ding K, Li Z. Oxidant-Induced Bioconjugation for Protein Labeling in Live Cells. ACS Chem Biol 2023;18:112-22. [PMID: 36543757 DOI: 10.1021/acschembio.2c00740] [Reference Citation Analysis]
2 Hou B, Chen T, Zhang H, Li J, Wang P, Shang G. The E3 ubiquitin ligases regulate PD-1/PD-L1 protein levels in tumor microenvironment to improve immunotherapy. Front Immunol 2023;14. [DOI: 10.3389/fimmu.2023.1123244] [Reference Citation Analysis]
3 Tsai M, Osman W, Adair J, ElMergawy R, Chafin L, Johns F, Farkas D, Elhance A, Londino J, Mallampalli RK. The E3 ligase subunit FBXO45 binds the interferon-λ receptor and promotes its degradation during influenza virus infection. J Biol Chem 2022;298:102698. [PMID: 36379255 DOI: 10.1016/j.jbc.2022.102698] [Reference Citation Analysis]
4 Song Z, Wang X, Chen F, Chen Q, Liu W, Yang X, Zhu X, Liu X, Wang P. LncRNA MALAT1 regulates METTL3-mediated PD-L1 expression and immune infiltrates in pancreatic cancer. Front Oncol 2022;12:1004212. [DOI: 10.3389/fonc.2022.1004212] [Reference Citation Analysis]
5 Wang Q, Wu L, Cao R, Gao J, Chai D, Qin Y, Ma L, Wu S, Tao Y, Ma J, Wang ZW. Fbxo45 promotes the malignant development of esophageal squamous cell carcinoma by targeting GGNBP2 for ubiquitination and degradation. Oncogene 2022. [PMID: 36127399 DOI: 10.1038/s41388-022-02468-7] [Reference Citation Analysis]
6 Lin M, Zhang J, Bouamar H, Wang Z, Sun LZ, Zhu X. Fbxo22 promotes cervical cancer progression via targeting p57(Kip2) for ubiquitination and degradation. Cell Death Dis 2022;13:805. [PMID: 36127346 DOI: 10.1038/s41419-022-05248-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Cao T, Cui Y, Wang Y, Wu L, Yu K, Chen K, Xia J, Li Y, Wang ZP, Ma J. CACNA1C-AS2 inhibits cell proliferation and suppresses cell migration and invasion via targeting FBXO45 and PI3K/AKT/mTOR pathways in glioma. Apoptosis 2022. [PMID: 36038736 DOI: 10.1007/s10495-022-01764-7] [Reference Citation Analysis]
8 Xu Z, Chen Q, Shu L, Zhang C, Liu W, Wang P. Expression profiles of m6A RNA methylation regulators, PD-L1 and immune infiltrates in gastric cancer. Front Oncol 2022;12:970367. [DOI: 10.3389/fonc.2022.970367] [Reference Citation Analysis]
9 Liu J, Leung CT, Liang L, Wang Y, Chen J, Lai KP, Tse WKF. Deubiquitinases in Cancers: Aspects of Proliferation, Metastasis, and Apoptosis. Cancers 2022;14:3547. [DOI: 10.3390/cancers14143547] [Reference Citation Analysis]
10 Xia L, Chen J, Huang M, Mei J, Lin M. The functions of long noncoding RNAs on regulation of F-box proteins in tumorigenesis and progression. Front Oncol 2022;12:963617. [DOI: 10.3389/fonc.2022.963617] [Reference Citation Analysis]